BANAN (cefpodoxime proxetil) · SANKYO
BANAN is FDA-approved to treat 10 conditions (same as CEFPODOXIME PROXETIL).
Details
- Status
- Discontinued
- First Approved
- 1992-08-07
- Routes
- ORAL
- Dosage Forms
- FOR SUSPENSION, TABLET
BANAN Approval History
What BANAN Treats
10 indicationsBANAN is approved for 10 conditions since its original approval in 1992. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Acute Otitis Media
- Pharyngitis
- Tonsillitis
- Community-Acquired Pneumonia
- Acute Bacterial Exacerbation of Chronic Bronchitis
- Gonorrhea
- Anorectal Infection
- Skin and Skin Structure Infection
- Acute Maxillary Sinusitis
- Urinary Tract Infection
Same approved indications as CEFPODOXIME PROXETIL (same active ingredient).
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT03491748 | CS0282-2017-0001 1010452 | Ph 1 | completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Processes a Substance) of ETX0282 When Administered Orally to Healthy Participants |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
BANAN FDA Label Details
Indications & Usage
FDA Label (PDF)BANAN is FDA-approved to treat 10 conditions — same approved indications as CEFPODOXIME PROXETIL.
Track BANAN with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.